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The prevalence of diabetes mellitus is increasing 
rapidly worldwide. Diabetes currently affects 366 
million people globally, and the number is expected 
to rise to 552 million by the year 2030.[1,2] In South 
Africa (SA) 3 million men and women have diagnosed 
diabetes, and there are an estimated further 3 million living with the 
disease who remain undiagnosed.[1]
Fetal complications of maternal diabetes can be divided into two major 
categories: (i) early complications, reflecting the impact of maternal 
disease on early fetal development due to poor glucose control during the 
period of organogenesis in the first trimester; and (ii) late complications, 
including unexplained stillbirths and macrosomia in the second and 
third trimesters and hypoglycaemia, respiratory distress syndrome 
and jaundice in the neonatal period. Direct obstetric complications 
include spontaneous miscarriage, pre-eclampsia, polyhydramnios and 
obstructed labour because of macrosomia.[3,4]
Maternal complications of pre-existing diabetes can be equally 
severe, and even life-threatening, but are often ignored by women 
desperate to have a child.
The 2007 Saving Mothers report stated that 76% of women with 
pre-existing maternal disease attended antenatal clinics.[5] The health 
system is therefore in a good position to intervene and prevent death, 
yet pre-existing maternal disease (6%) remains one of the five leading 
causes of maternal deaths, both in SA and internationally.[5] This 
suggests that antenatal intervention is too late to initiate optimal care 
for some patients, and that there is a lack of preconception planning 
and counselling, which are central to good management.
The 2007 Saving Mothers report stated that ‘the best way to 
prevent maternal deaths is to prevent pregnancy’.[5] One of its 
recommendations was to promote contraceptive use through 
education and service provision. This also promotes reproductive 
health. Women with unplanned pregnancies, especially those with 
an underlying medical condition such as pregestational diabetes, are 
at an increased risk of maternal and neonatal complications. Tight 
glycaemic control for diabetic women in the periconception period is 
essential to reduce the risks of complications.[6]
There are limited SA data on chronic medical diseases and 
contraceptive use and knowledge, with the exception of HIV. The 
2003 South Africa Demographic and Health Survey (SADHS) 
2003 data[7] are already more than 10 years old, and we have not 
been able to find anything more on chronic medical disorders and 
contraception in recent published research.
Objectives
To assess the reproductive knowledge of diabetic women of 
reproductive age attending outpatient clinics for the management 
of diabetes, and their use of contraception. A secondary objective 
was to elicit what counselling women with diabetes received on 
the implications of their condition with regard to pregnancy and 
reproductive health.
Methods
Study design and population
A prospective descriptive study design was used. The study population 
comprised women aged 18 - 45 years attending diabetes outpatient 
clinics between 1 March and 31 July 2012.
Recruitment was by convenience sampling, and patients were initially 
recruited from the three diabetes clinics at Groote Schuur Hospital 
Reproductive knowledge and use of contraception 
among women with diabetes
Ayesha Osman, MB ChB, FCOG (SA), MMed (O&G); Anne Hoffman, RN, RM; Shane Moore, RN, RM;  
Zephne van der Spuy, MB ChB, PhD, FRCOG, FCOG (SA)
Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital,  
Cape Town, South Africa
Corresponding author: A Osman (ayesha2309@gmail.com)
Background. Poorly controlled diabetes is associated with poor maternal and fetal outcomes, yet many women become pregnant before 
establishing control. Reducing unintended pregnancies is a vital step towards improving perinatal and maternal morbidity and mortality.
Objectives. To assess the reproductive knowledge and use of contraception in women of reproductive age attending diabetes outpatient 
clinics.
Methods. A prospective descriptive study was conducted of women known to have diabetes, aged 18 - 45 years, attending the diabetic 
clinics at Groote Schuur Hospital or the local community health centres in Cape Town, South Africa. A questionnaire consisting of social, 
demographic and family details as well as contraceptive use and knowledge was administered.
Results. Some common themes emerged, namely that 44.2% of the women with previous pregnancies had had unintended 
pregnancies, and that this was more common among single (58.8%) and younger women. Women with type 1 diabetes had better 
knowledge than those with type 2 diabetes of how pregnancy affects diabetes, but better knowledge did not translate to better 
contraception use. Despite the fact that 102 participants (88.7%) attended diabetes clinics two or more times a year, knowledge of 
pregnancy- and reproductive health-related complications was limited, and only 30 participants (26.1%) had received advice on 
contraception at these clinics.
Conclusion. Knowledge about the impact of diabetes on pregnancy and that of pregnancy on diabetes was suboptimal. We recommend that 
reproductive health services be included at the routine diabetes clinic visit.
S Afr Med J 2015;105(9):760-764. DOI:10.7196/SAMJnew.8170
RESEARCH
761       September 2015, Vol. 105, No. 9
(GSH), Cape Town, SA. The recruitment area 
was later extended to include community 
health centres (CHCs) with ‘diabetes clubs’ 
(Woodstock, Lady Michaelis, Hanover Park 
and Gugulethu CHCs).
Data collection
Data were collected by means of a 
questionnaire administered by experienced 
research staff in the Reproductive Medicine 
Unit, GSH. Additional clinical information 
was obtained from the medical folder.
The study investigators were not involved 
in the medical management of the patients. 
Interviews were conducted in private rooms 
to maintain strict confidentiality, and personal 
identifying information was not entered into 
the database. The questionnaire consisted of 
demographic and social details of patients as 
well as medical and obstetric history, knowledge 
about reproduction and contraception use.
Consent
Approval for the study was granted by the 
Human Research Ethics Committee of the 
Faculty of Health Sciences, University of 
Cape Town (HREC REF: 500/2011) and the 
Provincial Health Research Council of the 
Western Cape (RP 48/2012). All participants 
provided signed informed consent before the 
questionnaire was administered.
Data management and statistical 
analysis
Data were processed in the Reproductive 
Medicine Unit. All data were double-entered 
into a database created using Microsoft Office 
Excel 2007 and then cross-checked using the 
statistical analysis programme Stata. Statistical 
analysis was performed using Stata software 
version 11 (StataCorp 2009, USA), with 
assistance from the Department of Statistical 
Sciences of the University of Cape Town.
Demographic details were presented in 
a descriptive manner. In the analysis of 
continuous data such as age and parity, which 
are non-normally distributed, we used the 
Mann-Whitney U-test/Wilcoxon rank sum 
test for formal comparisons. In the case of 
categorical variables, cross-tabulations were 
used together with χ2 tests of association and 
Fisher’s exact tests where appropriate. The 
level of significance was set as p<0.05.
Results
Patient characteristics
A total of 115 women aged 18 - 45 years were 
recruited. No patient declined to participate. 
Less than half of the participants were 
employed (41.7%, n=48), but no woman 
identified herself as being without financial 
support. Of note, 19 participants were 
receiving disability grants and four received 
child support grants which they cited as 
financial support. The majority of the 
participants lived in a dwelling with access to 
basic amenities (water, electricity, plumbing), 
and less than 10% (n=11) lived in an informal 
dwelling without these amenities.
Sixty-two respondents (53.9%) had com-
pleted a minimum of grade 12 level of 
education, and only four (3.5%) had less 
than a grade 7 education. Sixty-seven women 
(58.3%) were either married or in a stable 
relationship (Fig. 1). Only one participant 
was unable to identify a source of emotional 
support.
Obstetric history
The 77 women who had previously been 
pregnant had a total of 180 pregnancies between 
them. Of these women, 34 (44.2%) reported 
some of their pregnancies as unintended. The 
Mann-Whitney U-test/Wilcoxon rank sum test 
demonstrated an association between age and 
intended pregnancy, unintended pregnancy 
tending to be associated with younger age 
(z=2.308, p=0.0210).
Single women were also more likely to 
have had unintended pregnancies, with 20 
of the reported 34 unintended pregnancies 
(58.8%) having been in women who classified 
themselves as single (Pearson χ2(6)=16.8552, 
Fisher’s exact p=0.003). The remaining 14 
women, who were currently married, did not 
specify whether the unintended pregnancy 
had occurred before or after marriage.
Only 10 of the 43 women (23.3%) who 
reported having had an intended pregnancy 
identified themselves as single; the remaining 
33 (76.7%) were currently married, divorced 
or separated, but as their marital status at the 
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Fig. 1. Marital status of the study subjects.
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time of the pregnancy was not specified, this 
information should be interpreted with caution.
We found no association between 
educational level and emotional support and 
intended v. unintended pregnancies (Pearson 
χ2(9)=10.6226, Fisher’s exact p=0.250 and 
Pearson χ2(1)=0.8011, Fisher’s exact p=1.000, 
respectively.)
A high proportion of the respondents who 
had been pregnant reported that they had 
been offered contraception after the birth 
of the baby (151 of 180 pregnancies, 83.9%). 
Despite this high number, in the group of 
34 women with unintended pregnancies, 24 
were not using any contraception at the time 
of conception.
Medical history
Sixty-one participants (53.0%) had type 1 
diabetes (requiring insulin from the time 
of diagnosis), and 70 were using additional 
medication such as antihypertensives and 
statins.
Eighty-five women (73.9%) had comorbid 
conditions or compli cations secondary to 
diabetes (most commonly hypertension 
and dylipidaemia) (Fig. 2). We found 
no association between complications of 
diabetes or comorbid disease and current 
or previous use of contraception (Pearson 
χ2(1)=0.1780, Fisher’s exact p=0.826).
Patients with type 1 diabetes did not 
differ from those with type 2 diabetes with 
regard to number of intended pregnancies 
and unintended pregnancies (Pearson 
χ2(1)=1.9057, Fisher’s exact p=0.248). We 
also found no association between type of 
diabetes and knowledge of complications 
(Pearson’s χ2(1)=1.3587, Fisher’s exact 
p=0.343). However, women with type 1 
diabetes demonstrated better knowledge 
of how pregnancy affects diabetes (26/61, 
42.6%) than those with type 2 diabetics 
(12/54, 22.2%), (Pearson χ2(1)=5.3881, 
Fisher’s exact p=0.029). Women with 
type 1 diabetes reported a lower rate 
of contraception use than those not 
using insulin (type 2 diabetes) (Pearson 
χ2(1)=3.3556, Fisher’s exact p=0.082).
Of the respondents, 90.4% (n=104) had 
some knowledge of the complications of 
diabetes. It is noteworthy, however, that 
knowledge of pregnancy- and reproductive 
health-related complications was limited in 
our study population (Fig. 3). There was 
no association between the number of 
clinic visits and the knowledge participants 
displayed (Pearson χ2(3)=0.7514, Fisher’s 
exact p=0.881). Knowledge of complications 
of diabetes did not impact on whether patients 
were currently using contraception (Pearson 
χ2(1)=0.4187, Fisher’s exact p=0.527).
Sixty-three respondents (54.8%) were unable 
to identify how diabetes affected a pregnancy, 
and 77 (67.0%) had no knowledge of how 
pregnancy affected diabetes. This was despite 
the fact that 102 participants (88.7%) had 
access to diabetes clinic staff at their regular 
clinic visits, which occurred at least every 
6 months. There was also no association 
between women’s knowledge of how diabetes 
affects a pregnancy and current use of 
contraception (Pearson χ2(1)=0.1488, Fisher’s 
exact p=0.846), and no association between 
knowledge of how pregnancy affects diabetes 
and current use of contraception (Pearson 
χ2(1)=2.5499, Fisher’s exact p=0.150). We also 
showed no difference in contraception uptake 
among participants in relation to the number 
of clinic visits (Pearson χ2(3)=3.66, Fisher’s 
exact p=0.263).
In respect of knowledge of patients 
with diabetes about their disease and their 
demographic profile, the only association 
we found was between marital status 
and knowledge of how diabetes affects a 
pregnancy, single women being less likely 
to know how diabetes affected a pregnancy 
(Pearson χ2(2)=7.8510, Fisher’s exact 
p=0.018). Multiple confounders could be 
present if looking at marital status alone, and 
we attempted to adjust for age and parity.
Contraceptive history
Women were asked, without prompting, to 
name methods of contraception they had 
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heard of, methods of contraception they had used in the past, 
and methods of contraception they were currently using (Fig. 4). 
Significant findings were that 12 participants (10.4%) had never used 
contraception and a further 38 (33.0%) were not currently using 
contraception.
Only 26.1% of the participants (n=30) had previously received 
contraceptive advice at the diabetes clinic, and an overwhelming 
majority (88.7%, n=102) felt uncomfortable about asking for 
advice there. Of particular note, 73.9% (n=85) indicated that they 
would like their diabetes doctor/sister to initiate a discussion 
about contraception. The most common place identified to access 
contraception was a family planning clinic (54.8%, n=63), but other 
outlets were also mentioned. Significantly, no woman identified the 
diabetes clinics as a source of contraception.
We found no association between parity, level of education, 
emotional support or lifestyle and contraceptive use. In the case of 
marital status, we found an increased association between being 
single and not using contraception when compared with married 
women or women in stable relationships (Pearson χ2(2)=7.9214, 
Fisher’s exact p=0.025).
Discussion
The themes that emerged from this study were that women attending 
outpatient diabetes clinics in our services have a limited knowledge 
of the impact of diabetes on pregnancy outcome, as well as on 
the impact of pregnancy on disease progression. Counselling on 
reproductive health, contraception and the effect of diabetes in 
pregnancy appears to be inadequate. This is supported by the 
fact that a large proportion of participants in our study (34/77, 
44.2%) reported unintended pregnancies, indicating that their use of 
contraception was suboptimal. Although women with type 1 diabetes 
had a better understanding than those with type 2 diabetes of how 
pregnancy affects diabetes, there was still low use of contraception 
among these patients that we cannot explain.
Studies in the USA have reported that in general women at 
highest risk of unintended pregnancies are unmarried and of low 
socioeconomic status, have a low literacy level, and belong to 
minority groups. These women also tend to have poor glycaemic 
control and are less likely than other women to talk to their doctor 
before planning a pregnancy. They usually present for antenatal care 
at a late gestational age, which makes it difficult to provide optimal 
care.[8-10]
Our study showed an association between younger age and 
unintended pregnancies, as well as between single status and 
unintended pregnancies. It is a misconception that women who 
are not currently in a sexual relationship do not need contraceptive 
advice. Sexual activity is a status that can change suddenly, and all 
women of reproductive age, particularly those with high-risk medical 
conditions, should have contraceptive counselling irrespective of 
their current status as defined by the SADHS. Waiting till they 
become sexually active can be too late for some.
Women with diabetes need to remain on contraception until 
optimal glucose control is achieved, chronic medications are adjusted 
and lifestyle adjustments (e.g. smoking cessation) have been made; 
this should be reiterated at every visit.
Adequate glycaemic control at the time of conception and during 
the period of organogenesis in early pregnancy reduces the risks 
of congenital malformations and spontaneous miscarriages to 
virtually the same as those in women without diabetes. International 
recommendations are haemoglobin A1c levels <7% (American 
Diabetes Association (ADA) guidelines) and <6.1% (UK National 
Institute of Clinical Excellence (NICE) guidelines).[11,12]
All but one of the women in our study were using some form of 
medical treatment (114/115). These included oral agents, insulin, 
antihypertensives and statins, some of which need to be revised 
during pregnancy. Despite the risk associated with pregnancy, our 
data showed that 12 of the participants (10.4%) had never used 
contraception, and a further 38 (33.0%) were not currently using 
contraception. The importance of contraception did not appear to 
feature in the otherwise excellent counselling they received in the 
diabetes clinics.
We found that only 30 of the study participants (26.1%) had 
previously received any contraceptive or pregnancy planning advice 
at the diabetes clinics. Varughese et al.[13] concluded in a 2007 review 
of women attending adult general diabetes clinics in Telford, UK, that 
the aim of diabetes services should be to enable the pregnant woman 
with diabetes to present to her obstetrician with such well-controlled 
levels that her pregnancy will proceed without any complications.
Studies by Schwarz et al.[9] and Chuang et al.[14] both demonstrated 
that despite relatively frequent contact with healthcare providers, 
adolescent women with diabetes rarely identified a doctor or nurse as 
a major source of information about contraception and furthermore 
that they did not feel comfortable asking a healthcare professional for 
advice about contraception. Our findings were similar in that despite 
the fact that 89% of the participants were attending specialist diabetes 
clinics two or more times a year for routine visits, none identified the 
clinic as a point of contact for their contraception needs.
It is of concern that women attending diabetes clinics three or four 
times a year may neglect their family planning clinic appointments, 
as they perceive these to be less important. It falls to the doctor or 
nurse in the general clinics to make access to these services as easy 
as possible, especially when they can be accessed in the same facility.
Women with chronic medical conditions are at an increased risk 
of pregnancy-related complications, yet little research (with the 
exception of research among HIV-positive patients) has addressed 
how they perceive their pregnancy-associated risks or make 
reproductive health choices.
Crede et al.[15] showed in a study among postpartum women in 
Cape Town that the majority of the subjects in both the HIV-positive 
and HIV-negative sample groups indicated that their last pregnancy 
had been unintended (61.6% and 63.2%, respectively). Nearly 90% of 
women in both groups reported they were using a modern method 
of contraception (89.8% of HIV-positive and 89.0% of HIV-negative 
women), but typically this was a short-acting method with a higher 
failure rate than the long-acting reversible contraceptives. This 
was very similar to the types of contraception identified by the 
participants in our study.
Women with diabetes are generally aware that they have a risk of 
complications, but they have very little knowledge about the risk of 
pregnancy-related complications.[14] This was illustrated in our study, 
where 104 of the 115 patients interviewed had some knowledge of 
the complications of diabetes. When pregnancy- and reproductive 
health-related complications were looked at more specifically, 
however, knowledge was limited: 63 respondents (54.8%) were unable 
to identify how diabetes affected a pregnancy, and 77 (67.0%) were 
unable to suggest any way in which pregnancy could affect diabetes.
Conclusion
Contraceptive advice and pregnancy planning discussions should 
form part of the clinical review of every woman in the general 
diabetes clinic, and should be initiated in their early reproductive 
years.[13]
Ideally, women with diabetes should conceive when they are 
best prepared for a pregnancy, financially, socially and medically. 
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Improved patient motivation, intensive input from diabetes services, 
and interdisciplinary interactions between the obstetric and medical 
teams managing these high-risk patients should form the essential 
components of care if we are to successfully address the challenge 
of reducing the current unacceptably high rates of maternal and 
perinatal morbidity and mortality in SA.
Acknowledgements. We appreciate the support we received from the staff 
in the diabetes clinics and thank the Department of Internal Medicine, 
GSH, for allowing us to conduct this research within their clinics. This 
research was partly sponsored by the JS Scratchley Trust.
References
1. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: IDF, 2013. http://
www.idf.org/diabetesatlas (accessed 17 February 2015). 
2. Federation of European Nurses in Diabetes and International Diabetes Federation – Europe. Diabetes: 
The Policy Puzzle: Is Europe making progress? 2nd ed. International Diabetes Federation, 2008:3-6. 
https://www.idf.org/sites/default/files/EU-diabetes-policy-audit-2008%20-2nd%20edition.pdf (accessed 
11 August 2015).
3. Kitzmiller JL, Block JM, Brown FM, et al. Managing pre-existing diabetes for pregnancy: Summary 
of evidence and consensus recommendations for care. Diabetes Care 2008;31(5):1060-1079. [http://
dx.doi.org/10.2337/dc08-9020]
4. Walkinshaw SA. Type 1 and type 2 diabetes and pregnancy. Curr Obstet Gynaecol 2004;14(6):375-386. 
[http://dx.doi.org/10.1016/j.curobgyn.2004.07.002]
5. National Committee on Confidential Enquiries into Maternal Deaths. Saving Mothers 2005-2007: 
Fourth Report on Confidential Enquiries into Maternal Deaths in South Africa: Expanded Executive 
Summary. Pretoria: Department of Health, 2009.
6. McDonagh M. Is antenatal care effective in reducing maternal morbidity and mortality? Health Policy 
Plan 1996;11(1):1-15. [http://dx.doi.org/10.1093/heapol/11.1.1]
7. Department of Health, Medical Research Council, OrcMacro. South Africa Demographic and Health 
Survey 2003. Pretoria: Department of Health, 2007.
8. Dunlop AL, Jack BW, Bottalico JN, et al. The clinical content of preconception care: Women with 
chronic medical conditions. Am J Obstet Gynecol Supplement to December 2008;199(6,Suppl 
B):s310-s327. [http://dx.doi.org/10.1016/j.ajog.2008.08.031]
9. Schwarz EB, Sobota M, Charron-Prochownik D. Perceived access to contraception among adolescents 
with diabetes: Barriers to preventing pregnancy complications. Diabetes Educ 2010;36(3):489. [http://
dx.doi.org/10.1177/0145721710365171] [PMID: 20332282]
10. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30(1):24-29,46. 
[http://dx.doi.org/10.2307/2991522]
11. American Diabetes Association. Standards of medical care in diabetes – 2010. Diabetes Care 
2010;33(1):s11-s61. [http://dx.doi.org/10.2337/dc10-S011]
12. Guideline Development Group. Guidelines: Management of diabetes from preconception to the 
postnatal period: Summary of NICE guidance. BMJ 2008;336(7646):714-717. [http://dx.doi.
org/10.1136/bmj.39505.641273.AD] 
13. Varughese GI, Chowdhury SR, Warner DP, Barton DM. Preconception care of women attending adult 
general diabetes clinics – are we doing enough? Diabetes Res Clin Pract 2007;76(1):142-145. [http://
dx.doi.org/10.1016/j.diabres.2006.07.025] 
14. Chuang CH, Velott DL, Weisman CS. Exploring knowledge and attitudes related to pregnancy 
and preconception health in women with chronic medical conditions. Matern Child Health J 
2010;14(5):713-719. [http://dx.doi.org/10.1007/s10995-009-0518-6]
15. Crede S, Hoke T, Contant D, et al. Factors impacting knowledge and use of long acting and permanent 
contraceptive methods by postpartum HIV positive and negative women in Cape Town, South Africa: 
A cross-sectional study. BMC Public Health 2012;12:197. [http://dx.doi.org/10.1186/1471-2458-12-197]
Accepted 30 June 2015.
